About Neurocea

About company

Neurocea Pharmaceuticals is a biopharmaceutical company dedicated to developing and commercializing innovative small molecule therapeutics for the treatment of neurodegenerative disorders. Neurocea’s lead product successfully completed Phase 2 clinical trials for treatment of L-Dopa induced dyskinesias (LIDs) in Parkinson’s patients